Are Cannabinoid-Derived Drugs the Future of Medicine?
Less than a year ago, FDA approved the first cannabinoid-derived drug, Epidiolex. It’s a […]
15
05, 2019
8
05, 2019
The Power of Patient Registries: How to Collaborate with Patients to Enhance Orphan Drug Research
Each year, doctors diagnose about 1,000 Americans with cystic fibrosis, a rare hereditary disease that affects […]
1
05, 2019
Is Gut Microbiome Behind Our Next Breakthrough Therapy?
“Microbiome” has become a consumer product buzzword, found in advertisements for soap and dozens […]
24
04, 2019
Patient Recruitment Solution: How to Ease Fear of the Unknown in Clinical Trials
The numbers vary but multiple surveys confirm what we all know: patient recruitment is […]
18
04, 2019
Cellular Therapy in Neurological Diseases: The Latest Advances and Challenges
Neurological disorders and diseases affect all ages and ethnicities, and most result in long-term disability […]
17
04, 2019
Advances in Non-Opioid Options for Post-Operative Pain Management
In a statement last August, departing FDA Commissioner Scott Gottlieb outlined several steps the agency had […]
4
04, 2019
Introducing Biorasi’s Center of Excellence: Neurology and Regenerative Medicine
Advances in stroke management, the first cannabinoid-derived drug approved, new therapeutics for progressive multiple […]
27
03, 2019
When Virtual Trials Are Not the Answer
Business as usual is not an option for conducting #clinicaltrials in the wake of the #COVID19 pandemic. Customized solutions and #patientcentricity are more optimal approaches in this environment. Jimmy El Hokayem, Ph.D., Associate Director of Program Development and Head of the Neurology and Regenerative Medicine Center of Excellence at Biorasi, shares his insights into #directtopatienttrials
21
03, 2019
Dermatology Detectives: How the Right Principal Investigator can Increase Patient Trust and Compliance
The success of a clinical trial depends largely on the engagement and experience of the PI. In addition to identifying and recruiting patients, site PIs and their teams conduct study procedures, complete study documentation, and retain patients for outcome assessments.
15
03, 2019
How to Minimize Subjectivity in Dermatology – Part 1: Principal Investigators & Clinical Staff
The success of any clinical trial depends on unbiased data. However, the subjective nature […]
7
03, 2019
Is Your Clinical Trial in Need of a Rescue?
Recognizing early warning signs that your trial is in trouble, and taking quick decisive action, can often get studies back on track. Improving operations can solve most failure risk factors, thus increasing the odds of success.
27
02, 2019
Cosmeceuticals: How to Navigate the Legal and Regulatory Hurdles of a Growing Market
The cosmeceuticals market continues its steady climb upward—a rise in disposable income plays a […]
